NYSE:RBOT

Vicarious Surgical - RBOT Stock Forecast, Price & News

$2.46

+0.20 (+8.85%)

(As of 03/21/2023 12:00 AM ET)

Add

Compare

Today's Range: $2.30
▼
$2.47
50-Day Range: $2.24
▼
$3.50
52-Week Range: $1.69
▼
$6.00

Volume: 175,429 shs
Average Volume: 297,157 shs
Market Capitalization: $309.86 million

P/E Ratio: 82.00
Dividend Yield: N/A
Price Target: $6.00

Institutional Ownership

Vicarious Surgical MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 143.9% Upside
$6.00 Price Target
Short Interest: Bearish
18.58% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Acquiring Shares
$880,955 Bought Last Quarter
Proj. Earnings Growth: Decreasing
From ($0.56) to ($0.64) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.24 out of 5 stars

Medical Sector

219th out of 983 stocks

Surgical Appliances & Supplies Industry

8th out of 23 stocks

3.5

Analyst's Opinion

Consensus Rating
Vicarious Surgical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $6.00, Vicarious Surgical has a forecasted upside of 143.9% from its current price of $2.46.
Amount of Analyst Coverage
Vicarious Surgical has received no research coverage in the past 90 days.

0.0

Short Interest

Percentage of Shares Shorted
18.58% of the float of Vicarious Surgical has been sold short.
Short Interest Ratio / Days to Cover
Vicarious Surgical has a short interest ratio ("days to cover") of 12.6, which indicates bearish sentiment.
Change versus previous month
Short interest in Vicarious Surgical has recently increased by 0.37%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Vicarious Surgical does not currently pay a dividend.
Dividend Growth
Vicarious Surgical does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for RBOT.

3.0

News and Social Media Coverage

News Sentiment
Vicarious Surgical has a news sentiment score of 1.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.34 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Vicarious Surgical this week, compared to 1 article on an average week.
Search Interest
27 people have searched for RBOT on MarketBeat in the last 30 days. This is an increase of 108% compared to the previous 30 days.
MarketBeat Follows
Only 5 people have added Vicarious Surgical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

4.2

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Vicarious Surgical insiders have bought 333.27% more of their company's stock than they have sold. Specifically, they have bought $880,955.00 in company stock and sold $203,325.00 in company stock.
Percentage Held by Insiders
52.48% of the stock of Vicarious Surgical is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
42.77% of the stock of Vicarious Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Vicarious Surgical are expected to decrease in the coming year, from ($0.56) to ($0.64) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Vicarious Surgical is 82.00, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 128.48.
Price to Earnings Ratio vs. Sector
The P/E ratio of Vicarious Surgical is 82.00, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 147.48.
Price to Book Value per Share Ratio
Vicarious Surgical has a P/B Ratio of 2.80. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Vicarious Surgical (NYSE:RBOT) Stock

Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Receive RBOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vicarious Surgical and its competitors with MarketBeat's FREE daily newsletter.

RBOT Stock News Headlines

March 15, 2023 | americanbankingnews.com

Vicarious Surgical Inc (NYSE:RBOT) Director Philip Liang Acquires 49,800 Shares of Stock

March 12, 2023 | americanbankingnews.com

Insider Buying: Vicarious Surgical Inc (NYSE:RBOT) Director Acquires 37,100 Shares of Stock

March 22, 2023 | Investing Daily (Ad)

This Trade Strategy Outpaces Almost Anything

Despite the volatility of the last few years, this reclusive millionaire hasn’t closed a losing trade since July 2016. He just plugs away, executing what may be the most effective investment strategy on Earth. He turned $50K into $5.3M! Want to see the details? Click HERE to watch it for yourself.

February 16, 2023 | finance.yahoo.com

Vicarious Surgical Inc. (NYSE:RBOT) Q4 2022 Earnings Call Transcript

February 14, 2023 | bizjournals.com

Vicarious Surgical's shares pop following 14% workforce reduction

February 14, 2023 | msn.com

Vicarious Surgical rises after announcing layoffs

February 14, 2023 | finanznachrichten.de

Encision, Inc.: Encision Signs Proof of Concept Agreement with Vicarious Surgical Inc.

February 14, 2023 | finance.yahoo.com

Encision Signs Proof of Concept Agreement with Vicarious Surgical Inc.

March 22, 2023 | Weiss Ratings (Ad)

Urgent Warning

This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …

February 13, 2023 | finance.yahoo.com

Vicarious Surgical Reports Fourth Quarter and Full Year 2022 Financial Results

February 10, 2023 | msn.com

Earnings Preview: Vicarious Surgical

January 30, 2023 | finance.yahoo.com

Vicarious Surgical to Report Fourth Quarter and Full Year 2022 Financial Results on February 13, 2023

December 22, 2022 | finance.yahoo.com

Vicarious Surgical Completes Public Demonstration of Beta 2 Surgical Robotic System

November 17, 2022 | finance.yahoo.com

Vicarious Surgical Partners with Renowned Surgeon to Successfully Perform Two Cadaveric Ventral Hernia Procedures

November 14, 2022 | finance.yahoo.com

Vicarious Surgical to Participate in Upcoming Conferences

November 10, 2022 | bizjournals.com

Pittsburgh CREATES in partnership with surgical firm

November 10, 2022 | technews.tmcnet.com

Vicarious Surgical System Named to TIME's List of the Best Inventions of 2022

November 10, 2022 | time.com

One Tiny Incision

November 10, 2022 | finance.yahoo.com

Vicarious Surgical System Named to TIME’s List of the Best Inventions of 2022

November 8, 2022 | seekingalpha.com

Vicarious Surgical Inc. (RBOT) Q3 2022 Earnings Call Transcript

November 7, 2022 | finance.yahoo.com

Vicarious Surgical Reports Third Quarter 2022 Financial Results

November 4, 2022 | msn.com

Earnings Outlook For Vicarious Surgical

October 24, 2022 | finance.yahoo.com

Vicarious Surgical to Report Third Quarter 2022 Financial Results on November 7, 2022

October 20, 2022 | finance.yahoo.com

Vicarious Surgical Announces Changes to Board of Directors

October 15, 2022 | finance.yahoo.com

While insiders own 21% of Vicarious Surgical Inc. (NYSE:RBOT), private equity firms are its largest shareholders with 28% ownership

October 13, 2022 | finance.yahoo.com

Vicarious Surgical Announces Upcoming Beta 2 Demonstration Day

September 3, 2022 | wsj.com

Vicarious Surgical Inc.

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive RBOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vicarious Surgical and its competitors with MarketBeat's FREE daily newsletter.

RBOT Company Calendar

Last Earnings: 2/13/2023
Today: 3/22/2023
Next Earnings (Estimated): 5/08/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Surgical appliances & supplies
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSE:RBOT
CUSIP: N/A
CIK: 1812173
Web: www.vicarioussurgical.com
Phone: 617 868 1700
Fax: N/A
Employees: 3
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $6.00
High Stock Price Forecast: $7.00
Low Stock Price Forecast: $5.00
Forecasted Upside/Downside: +143.9%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.03
Trailing P/E Ratio: 82.00
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $5.16 million
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -65.98%
Return on Assets: -49.67%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 14.35
Quick Ratio: 14.35

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.88 per share
Price / Book: 2.80

Miscellaneous

Outstanding Shares: 125,960,000
Free Float: 59,854,000
Market Cap: $309.86 million
Optionable: Optionable
Beta: 1.25

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

RBOT Stock - Frequently Asked Questions

Should I buy or sell Vicarious Surgical stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Vicarious Surgical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" RBOT shares.
View RBOT analyst ratings or view top-rated stocks.
What is Vicarious Surgical's stock price forecast for 2023?: 1 brokers have issued twelve-month price objectives for Vicarious Surgical's stock. Their RBOT share price forecasts range from $5.00 to $7.00. On average, they anticipate the company's share price to reach $6.00 in the next twelve months. This suggests a possible upside of 143.9% from the stock's current price.
View analysts price targets for RBOT or view top-rated stocks among Wall Street analysts.
How have RBOT shares performed in 2023?: Vicarious Surgical's stock was trading at $2.02 at the beginning of 2023. Since then, RBOT shares have increased by 21.8% and is now trading at $2.46.
View the best growth stocks for 2023 here.
When is Vicarious Surgical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 8th 2023.
View our RBOT earnings forecast.
How were Vicarious Surgical's earnings last quarter?: Vicarious Surgical Inc (NYSE:RBOT) issued its quarterly earnings results on Monday, February, 13th. The company reported ($0.16) EPS for the quarter, topping analysts' consensus estimates of ($0.18) by $0.02. During the same quarter last year, the business earned ($0.15) earnings per share.

What is Vicarious Surgical's stock symbol?: Vicarious Surgical trades on the New York Stock Exchange (NYSE) under the ticker symbol "RBOT."
Who are Vicarious Surgical's major shareholders?: Vicarious Surgical's stock is owned by many different retail and institutional investors. Top institutional shareholders include MY.Alpha Management HK Advisors Ltd (2.49%), DDD Partners LLC (1.54%), Geode Capital Management LLC (0.68%), Jane Street Group LLC (0.43%), Charles Schwab Investment Management Inc. (0.27%) and Morgan Stanley (0.18%). Insiders that own company stock include Adam David Sachs, June Morris, Philip Liang, Sammy Khalifa and William John Kelly.
View institutional ownership trends.
How do I buy shares of Vicarious Surgical?: Shares of RBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Vicarious Surgical's stock price today?: One share of RBOT stock can currently be purchased for approximately $2.46.
How much money does Vicarious Surgical make?: Vicarious Surgical (NYSE:RBOT) has a market capitalization of $309.86 million. The company earns $5.16 million in net income (profit) each year or $0.03 on an earnings per share basis.
How can I contact Vicarious Surgical?: Vicarious Surgical's mailing address is 78 Fourth Avenue Waltham, MA 02451. The official website for the company is www.vicarioussurgical.com. The company can be reached via phone at 617 868 1700 or via email at ir@vicarioussurgical.com.

This page (NYSE:RBOT) was last updated on 3/22/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Vicarious Surgical - RBOT Stock Forecast, Price & News

Vicarious Surgical MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Vicarious Surgical (NYSE:RBOT) Stock

RBOT Stock News Headlines

RBOT Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Competitors

Insiders & Institutions

RBOT Stock - Frequently Asked Questions

Overall MarketRank^™